Multicenter phase II study evaluating docetaxel, CDDP [cisplatin], and cetuximab as induction regimen prior to surgery in chemo-naive patients with NSCLC [non-small cell lung cancer] stage IB, II and IIIA.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Mar 2011 Planned end date changed from 1 Dec 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 26 Aug 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.